Innate Pharma and MedImmune will test the combination of Innate’s cancer antibody and the checkpoint inhibitor durvalumab in patients with solid tumors.
Betamore, Johns Hopkins Technology Ventures and the University of Maryland, Baltimore are looking for five local digital health, bio-health or life sciences companies to participate in a new collaborative accelerator program.
A new study from the Karolinska Institutet in Stockholm, Sweden, suggests that replacing time spent sitting with light-intensity physical activity may benefit health more than previously thought.
March 22, 2018 5:30 – 8:00 p.m.
The Grand Lodge of Maryland 304 International Cir Cockeysville, MD 21030
Influential Marylanders was created to honor individuals who have made significant impacts in their field and continue to be leaders in Maryland. These individuals are selected by The Daily Record’s editors for their significant contributions to their respective fields and for their leadership in Maryland in the following areas: civic leadership; communications; education; finance; freestyle; general business; health care; law; philanthropy; real estate; and technology. Three-time winners are inducted into the Circle of Influence.
Funding and Research Opportunities
The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:
Sophie Martyr was just 13 years old when she learnt she had brain cancer and was asked to make a decision about whether she wanted to have children in the future.
At many university TTOs, a historical focus on faculty research has resulted in relatively weak support for the student innovation ecosystem – and it’s a gap that many schools are now rushing to fill. It’s true that many universities hold student innovation contests and offer mentoring programs for the most promising business-minded students. But your TTO can go further by creating an ecosystem with a strong talent pool to not only build valuable start-ups, but keep these young entrepreneurs and their companies in the region, contributing to the local economy and creating an environment that’s attractive to outside investors and industry partners.
Three corporate behemoths — Amazon, Berkshire Hathaway and JPMorgan Chase — announced on Tuesday that they would form an independent health care company for their employees in the United States.
A Baltimore biotechnology company is raising up to $40.5 million and working to develop pharmaceutical technology born out of Johns Hopkins University.
The team at Roche’s Basel-based underdog R&D group pRED has something to cheer about today. The FDA has designated their autism drug RG7314 (balovaptan) as a “breakthrough” therapy worthy of VIP treatment at the agency.